Clinical Trials
3 trialsNCT00375739 2016-01-28
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
Peplin
Phase 2 Completed
NCT00107965 2015-03-25
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
Peplin
Phase 2 Completed
NCT00239135 2015-03-25
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Peplin
Phase 2 Completed